Page:United States Statutes at Large Volume 70.djvu/670

 614

PUBLIC LAW 764-JULY 24, 1956

[70 S T A T.

tional label to the original package of such drug and must immediately record such sale and delivery by filing a suitable record of such sale and delivery in the prescription file as maintained for prescriptions for such drugs; or (C) such dangerous drug is delivered by a manufacturer's representative or drug salesman to a practitioner in the course of calling upon the practitioner; in which case the manufacturer's representative or drug salesman shall immediately record, in a suitable bound notebook (i) the name and quantity of the drug delivered, (ii) the date such drug was delivered, and (iii) the name and address of the practitioner to whom the drug was delivered; or (D) such dangerous drug is delivered by a practitioner in the course of his practice and the immediate container in which such drug is delivered bears a label on which appears the directions for use of such drug, the name and address of such practitioner, the name and address of the patient, and, if such drug is prescribed for an animal, a statement of the species of the animal. (2) The refilling of any prescription for a dangerous drug except as designated on the prescription, or by the consent of the practitioner. (3) The delivery of a dangerous drug upon prescription unless the pharmacist who filled such prescription files and retains it as required by section 206 of this title. (4) The possession of a dangerous drug by any person, unless such person obtained such drug on the prescription of a practitioner or in accordance with subparagraph (D) of paragraph (1) of this subsection. (5) The making or uttering by any person of any false or forged prescription, or false or forged written order for the purpose of obtaining any dangerous drug. (6) The delivery of any dangerous drug to any person in the District of Columbia not lawfully entitled to receive such drug. (7) The willful making of or concealment of any material false statement or representation in any prescription, order, report, or record required by this title. (8) The refusal to make available and to accord full opportunity to check any record or file as required by section 207 of this title. (9) The failure to keep records as required by subsections (a) and (b) of section 206 of this title. (10) The using by any person to his own advantage, or the revealing, other than to any officer of the Metropolitan Police Department of the District of Columbia in the performance of his official duties, the Commissioners, acting pursuant to authority vested in them, or to a court when relevant in a judicial proceeding under this title, of any information required under the authority of section 207, concerning any method or process which as a trade secret is entitled to protection. (b) Nothing in this section shall be construed to relieve any person with respect to dangerous drugs, from any requirement prescribed by or under the authority of sections 502 and 503 (b) of the Federal Food, Drug, and Cosmetic Act (52 Stat. 1040; 21 U.S.C. 352, 353 (b)). EXEMPTIONS

SEC. 204. Nothing in this title shall apply to a compound, mixture, or preparation which is delivered or acquired in good faith for the purpose for which it is intended and not for the purpose of evading the provisions of this title if—

�